Billionaire hedge fund manager Carl Icahn has amassed a sizable stake in health insurance industry giant Cigna and plans to vote against its proposed US$54 billion acquisition of Express Scripts Holding when shareholders vote August 24, as first reported by The Wall Street Journal.
Icahn, a high-profile activist investor who once served as an advisor to President Trump, holds less than a 5% stake in the insurance company. He reportedly believes that Cigna is paying too high of a price for the pharmacy benefit manager (PBM), which faces various risks including consolidation of industry rivals and the entrance of e-commerce and cloud computing titan Amazon.
In December, insurance rival Aetna agreed to buy drugstore chain and PBM manager CVS Health in a deal worth US$69 billion. On Wednesday, August 1, California Insurance Commissioner Dave Jones released a report urging the US Justice Department to block the proposed tie up.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
